| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA4628554 | F | Antiproliferative activity against lenalidomide-resistant human H929-R10-1 cells incubated for 5 days by CellTiter-Glo assay | Homo sapiens | 39 | assay format | Scientific Literature | ||
| 2. | ALA4628555 | B | Induction of CRBN-mediated pLOC-ePL-tagged aiolos (unknown origin) degradation in human DF15 cells assessed as minimum protein remaining incubated for 4 hrs by luminescence based beta-galactosidase enzyme fragmentation complementation assay | Homo sapiens | 36 | cell-based format | Scientific Literature | ||
| 3. | ALA4628556 | B | Induction of CRBN-mediated pLOC-ePL-tagged aiolos (unknown origin) degradation in human DF15 cells assessed as minimum protein remaining up to 10 uM incubated for 4 hrs by luminescence based beta-galactosidase enzyme fragmentation complementation assay relative to control | Homo sapiens | 39 | cell-based format | Scientific Literature | ||
| 4. | ALA4628559 | B | Displacement of Cy5-conjugated CELMoD from N-terminal 6-His tagged CRBN (1 to 442 residues) (unknown origin)/DDB1 (1 to 1140 residues) (unknown origin) incubated for 10 mins by FRET assay | Homo sapiens | 12 | protein format | Scientific Literature | ||
| 5. | ALA4628560 | P | Drug metabolism in assay cell medium assessed as compound racemization measured within 24 hrs | 3 | small-molecule physicochemical format | Scientific Literature |
The page will load shortly, Thanks for your patience!